Coronavirus Cases Outside China Are Accelerating Rapidly. Here ’s What to Know

A surge in deadly coronavirus cases outside China is raising concerns that the outbreak has reached a new stage and could continue its global spread to even more vulnerable countries. In the central Chinese province of Hubei, where the virus is believed to have originated, the number of cases appears to be stabilizing, according to government figures. But the number of people infected elsewhere in the world is rising quickly, with clusters in South Korea, Italy, Iran and a cruise ship docked in Japan. As of Monday, more than 2,200 cases of the virus, officially called COVID-19, have been reported outside of mainland China, where the overwhelming majority of the 79,000 cases have been located since officials first discovered the disease in December. The number of deaths outside mainland China has also increased to 33, including 12 in Iran, eight in South Korea and four in Italy. In a news conference Monday, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said the WHO is “worried about the situation in the Islamic Republic of Iran and in Italy.” Although there have been a handful of people infected in more than 25 countries, the number of cases outside China remained in the hundreds for weeks, before jumping to around 1,000 cases on Feb. 18. But in the last few days, the number of infected people has skyrocketed in several countries, sparking fears that the virus could take root outside China. It took draconian measures, including lockin...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 onetime overnight Source Type: news

Related Links:

Abstract Coronavirus disease 2019 (COVID-19) surveillance, in Brazil, initiated shortly after its description, in China. Our aim was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and additional pathogens in samples from the initial phase of the outbreak in Brazil, from late February to late March. From 707 samples analysed, 29 (4.1%) were SARS-CoV-2 positive. Fever and cough were their most prevalent symptoms. Co-detection of rhinovirus was observed in 2 (6.9%) cases. Additional pathogens were identified in 66.1% of the SARS-CoV-2 negative cases, mainly rhinovirus and influenza A(H1N1)pdm0...
Source: Memorias do Instituto Oswaldo Cruz - Category: Infectious Diseases Authors: Tags: Mem Inst Oswaldo Cruz Source Type: research
Many months into the COVID-19 pandemic, the coronavirus is still spreading uncontrolled through the U.S. Public health authorities including the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) tell us to remain six feet apart, wash our hands, disinfect frequently touched surfaces, and wear masks. But compliance with these measures—especially masks—is mixed, and daily we hear of cases where people do not know how they were infected. We hear about superspreading events, where one person infects many, happening in crowded bars and family gatherings, but not at outdoor ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
In this study, therefore, we compared some clinical, demographic, and laboratory findings to determine the differences between H1N1 influenza and coronavirus disease-2019 (COVID-19) to suggest the appropriate drug therapeutic approaches. Subsequent to the inclusion of 4 available studies, which presented all the required data, the findings and results were compared, showing fever and cough as the most prevalent clinical indications of both H1N1 influenza and 2019-nCoV diseases. With respect to the laboratory findings, both 2019-nCoV and H1N1 patients showed leukopenia as the main laboratory findings. Taken together, since ...
Source: Clinical Pulmonary Medicine - Category: Respiratory Medicine Tags: Critical Care/Respiratory Care Source Type: research
BackgroundInitial reports describing coronavirus 2019 (COVID ‐19) were dominated by the presence of cough, breathlessness, and fever; anecdotal reports suggested anosmia may also be a manifestation. We used Google Trends (GT) to investigate whether there was a surge in individuals searching for information related to smell loss during the COVID‐19 epidemi c in Italy, Spain, the United Kingdom, the United States, Germany, France, Iran, and The Netherlands.MethodsGT was used to explore internet activity related to loss of smell in the 8 aforementioned countries. Spearman rank analysis was performed to correlate loss ‐o...
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: ORIGINAL ARTICLE Source Type: research
This study showed that a five-day regimen is as effective as 10 days–that’s important, doctors say, since it could mean shorter stays in the hospital, which could alleviate some of the burden on the health care system. “Of course we will have to wait for the final review of all the data, but it would be very nice to have an anti-viral that’s efficacious in this terrible illness,” says Dr. Aruna Subramanian, a clinical professor of medicine at Stanford and an investigator on the study. “At least we know that we can help patients with this, and that’s really the bottom line.” T...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 feature Magazine Source Type: news
Recently, a novel coronavirus (SARS-CoV-2) has caused a severe outbreak in many regions of the world. It has been a cause of severe respiratory infection in humans between December 2019 and March 2020 (Chan et al., 2020, Gralinski and Menachery, 2020, The Lancet, 2020). More than 87,000 individuals have been confirmed as infected with the virus in China as of 1 March 2020 and most cases were reported in Wuhan city (World Health Organization, 2020). SARS-CoV-2 most commonly manifests as an acute or subacute illness such as fever, cough, myalgia and fatigue.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Preliminary data from China suggest that people with diabetes and other preexisting conditions are more likely to experience serious complications and death from COVID-19 than people without diabetes and other conditions. But COVID-19 and the coronavirus that causes it are new, and researchers are still investigating how they impact immunity. We also know that if a person has diabetes and gets influenza or another infection, they can experience worse health outcomes. The question is why. High blood sugars can interfere with white blood cells’ ability to fight infection. So there’s a possibility that people with...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Diabetes Health Source Type: blogs
written by Dr. Stephen A. Berger For several years, the World Health Organization has been following a group of twenty-or-so Neglected Tropical Diseases. In the Developed World, these conditions are largely unknown to the general public, and even to physicians working in fields outside of Epidemiology and Infectious Diseases. In only three months, the list of neglected diseases has grown to include more than 360 infectious conditions – all because of a single new viral disease called COVID-19. As of this morning, 287 cases of COVID-19 had been reported in the DRC (Democratic Republic of Congo) resulting in 23 d...
Source: GIDEON blog - Category: Databases & Libraries Authors: Tags: Diagnosis Epidemiology Outbreaks Source Type: blogs
(BOISE, Idaho) — They are two disasters that require opposite responses: To save lives and reduce the spread of COVID-19, people are being told to remain isolated. But in a wildfire, thousands of firefighters must work in close quarters for weeks at a time. Wildfires have already broken out in Texas and Florida, and agencies are scrambling to finish plans for a new approach. They are considering waivers for some training requirements to previously-certified crew members, and moving some training online. Other proposals include limiting fire engines to a driver and one passenger, requiring other crew members to ride i...
Source: TIME: Science - Category: Science Authors: Tags: Uncategorized COVID-19 Environment News Desk wire Source Type: news
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: Afghanistan Health | Bahrain Health | Centers for Disease Control and Prevention (CDC) | China Health | Conferences | Coronavirus | Cough | COVID-19 | Epidemiology | France Health | Government | Health | Hong Kong Health | Hospitals | India Health | Infectious Diseases | Influenza | International Medicine & Public Health | Iran Health | Iraq Health | Italy Health | Japan Health | Kuwait Health | Laboratory Medicine | Legislation | Middle East Health | Outbreaks | Pakistan Health | Philippines Health | Respiratory Medicine | Science | South Korea Health | Study | Tropical Medicine | USA Health | Virology | Wales Health | Warnings | WHO